At Beef Sommelier, we provide our B-som Diagnosis with the aim of creating a world where producers can raise their ideal cattle and consumers can enjoy beef that truly matches their preferences. Our technology not only quantifies biological information from beef cattle, but also supports producers in achieving their target meat quality. By introducing a new scientific perspective that goes beyond conventional standards, we make the “unseen qualities” of beef visible and measurable. This enables consumers to clearly understand the characteristics of the beef they choose. B-som is the world’s first scientific diagnostic service that bridges the gap between producers and consumers.
株式会社ビーフソムリエ(本社:東京都品川区、代表取締役社長:松岡俊樹)は、2025年6月18日に札幌で開催された「The JSSA Sapporo Pitch Award & Power Matching Booth Vol.60」において、ファイナリスト6...
株式会社ビーフソムリエ(本社:東京都品川区、以下:ビーフソムリエ)は、世界で一番ブランド牛に詳しくなるために、「牛肉テロワールプロジェクト」を完成させる取り組みを続けていきます。世界中の牛肉を、産...
株式会社ビーフソムリエ(以下「ビーフソムリエ」、東京都品川区、代表取締役社長: 松岡俊樹)は、一般社団法人AgVenture Lab(以下「あぐラボ」、東京都千代田区、代表理事理事長: 荻野浩輝)より資金調達を行い...
データサイエンスの力で豊かな食文化を育む、をパーパスに掲げる株式会社ビーフソムリエ(本社:東京都品川区、代表取締役社長:松岡俊樹)は、"誰もが温かく繋がるカフェ" SY.ノートCafe とともに、親子で楽しめ...
[画像1: https://prtimes.jp/i/154461/1/resize/d154461-1-8b0038abb83e6bd627d5-6.jpg ] 近畿大学生物理工学部(和歌山県紀の川市)遺伝子工学科教授 松本和也は、肉用牛の将来の肉質等を採⾎検査によって可視化...

A startup overcoming challenges in exosome purification with proprietary high-purity, high-yield technology, offering end-to-end support from research to manufacturing. It accelerates practical applications in drug discovery, contributing to a new foundation for pharmaceutical development and driving medical innovation.

Cerebro Pharma was established in 2020 as an Osaka-based bio-venture with the mission to create a society free of dementia. We focus on research and development of healthcare products and pharmaceuticals specializing in the prevention and improvement of dementia and neurodegenerative diseases, and actively promote collaborative projects with major domestic pharmaceutical companies and academic institutions.

Development of cancer treatment equipment using optical electromagnetic waves

Millde is a technology-driven company specializing in multi-point Raman spectroscopy and high-sensitivity imaging. It provides non-destructive, label-free analysis of cells, tissues, and materials, primarily through contract research services. Serving regenerative medicine, pharmaceutical, food, and materials industries, Millde delivers high-throughput molecular evaluation. The company also develops and commercializes proprietary multi-point Raman systems and cryogenic Raman technologies, supporting applications from research to industrial implementation.